Stocks in news: Equity markets ended a three-week winning streak with a loss of over 1.5%, influenced by weak global cues. Key stocks in fo...

The drug will be manufactured at the company's manufacturing facility located in Gagillapur, Hyderabad, the filing said.

Granules has received marketing approval from the US Food and Drug Administration (USFDA) for Potassium Chloride extended release tablets U...

The company’s formulations business is expected to have grown 25% to Rs 3.6 billion.

Finished dosages and pharmaceutical formulation intermediates are manufactured at the plant, it said. Granules India stock was trading near...

The company had in January received eleven observations from Infarmed, the Portuguese drug regulator, for its facility located at Gagillapu...

We estimate that OmniChem is going to do anywhere from 180-200 crores revenues with an EBITDA of not less than 20 per cent.

At 10:00 am; Granules India was trading 6 per cent lower at Rs 104.60. It hit a low of Rs 97.75 and a high of Rs 107.40 in the first 45-min...

My problem with a company like Granules is that I really cannot bet on a company which is betting highly on a highly commoditised product, ...

8K Miles Software will announce its financial results for the quarter ended December 31, 2016 on Monday.

The main growth, the boost for growth of Granules India from now on would be in complex molecules and extended release, controlled release ...

Shares of drug maker Granules India today rose by nearly 5 per cent after the US drug regulator FDA inspected its manufacturing facility.

Granules India rallied as much as 11.92% in early trade after the USFDA found no observations after inspecting its Gagillapur facility.

Granules India today said US health regulator FDA has inspected its Gagillapur manufacturing facility near Hyderabad and did not find any d...

Mid-sized pharmaceutical company Granules India is eying to achieve Rs 1,000 crore of revenue during the current financial year 2013-14.

Hyderabad's real estate developer SatyaVani Green Homes to invest over ten million dollars in Udhodayam Green Homes.

Granules India on Monday said two of its facilities at Gagillapur and Bonthapally have received United States Food and Drug Administration'...